PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
Aralen (Chloroquine)- FDA 19 Drug Disease Infectious Diseases 33,605 1 0.00 -0.97 0.05 0.60
Aralen (Chloroquine)- FDA 19 Drug Disease Stroke 146,992 1 0.00 -0.97 0.05 0.57
Aralen (Chloroquine)- FDA 19 Drug Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Aralen (Chloroquine)- FDA 19 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Aralen (Chloroquine)- FDA 19 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Mu-Type Opioid Receptor 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
Amitiza (Lubiprostone)- FDA 19 Drug Disease Ileus 9,091 1 0.00 -0.97 0.05 0.63
Eotaxin-2/CCL24 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Eotaxin-2/CCL24 19 Target Disease Psoriasis 26,882 1 0.00 -0.97 0.05 0.60
Eotaxin-2/CCL24 19 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.05 0.65
Kallikrein-8 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Kallikrein-8 19 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kallikrein-8 19 Target Disease Glioblastoma 17,933 1 0.00 -0.97 0.05 0.61
Tegument Protein Vp16 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Tegument Protein Vp16 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Anesthesia Local 18 Disease Disease Bronchitis 18,336 1 0.00 -0.97 0.06 0.61
Anesthesia Local 18 Disease Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
Anesthesia Local 18 Disease Disease Cancer 1,053,491 1 0.00 -0.97 0.06 0.53
Anesthesia Local 18 Disease Disease Nausea 42,627 1 0.00 -0.97 0.06 0.59
Anesthesia Local 18 Disease Disease Infection 766,637 1 0.00 -0.97 0.06 0.53
Anesthesia Local 18 Disease Disease Stroke 146,992 1 0.00 -0.97 0.06 0.57
Anesthesia Local 18 Disease Disease Hypotension 42,123 1 0.00 -0.97 0.06 0.59
Anesthesia Local 18 Disease Disease Breast Cancer 173,695 1 0.00 -0.97 0.06 0.56
Anesthesia Local 18 Disease Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
Carcinoma Brain 18 Disease Disease Prostate Cancer 71,064 1 0.00 -0.97 0.06 0.58
Carcinoma Brain 18 Disease Disease Epilepsy 71,172 1 0.00 -0.97 0.06 0.58
Carcinoma Brain 18 Disease Disease Breast Cancer 173,695 1 0.00 -0.97 0.06 0.56
Carcinoma Brain 18 Disease Disease Brain Tumors 16,749 1 0.00 -0.97 0.06 0.61
Aldactone (Spironolactone)- FDA 18 Drug Disease Depression 220,092 1 0.00 -0.97 0.06 0.56
Aldactone (Spironolactone)- FDA 18 Drug Disease Arrhythmia 29,330 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Disease Ventricular Dysfunction 12,856 1 0.00 -0.97 0.06 0.62
Aldactone (Spironolactone)- FDA 18 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Aldactone (Spironolactone)- FDA 18 Drug Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
Aldactone (Spironolactone)- FDA 18 Drug Disease Infertility 35,448 1 0.00 -0.97 0.06 0.60
BMP-2B 18 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.06 0.63
Allopurinol (Zyloprim)- FDA 18 Drug Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.06 0.62
Allopurinol (Zyloprim)- FDA 18 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.06 0.57
Abatacept (Orencia)- FDA 18 Drug Disease Constipation 15,810 1 0.00 -0.97 0.06 0.62
Abatacept (Orencia)- FDA 18 Drug Disease Neutropenia 25,934 1 0.00 -0.97 0.06 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.06 0.65
Angiostatin K1-3 17 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Angiostatin K1-3 17 Target Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Avonex (Interferon beta-1a)- FDA 17 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Pancreatitis Chronic 16 Disease Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Pancreatitis Chronic 16 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Thromboembolic Disease 3,336 1 0.00 -0.97 0.06 0.66
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Renal Failure 73,993 1 0.00 -0.97 0.06 0.58
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Neuropathy Diabetic 15 Disease Disease Arrhythmia 29,330 1 0.00 -0.97 0.07 0.60
Neuropathy Diabetic 15 Disease Disease Diabetic Retinopathy 14,494 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Hyperlipidemia 15,317 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.07 0.55
Complement Component C3c 15 Target Disease Depression 220,092 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.07 0.53
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
Complement Component C3c 15 Target Disease Viral Disease 2,087 1 0.01 -0.97 0.07 0.67
Complement Component C3c 15 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.07 0.58
Glutathione Transferase Omega-1 14 Target Disease Hypoglycemia 20,698 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Ovarian Cancer 33,996 1 0.00 -0.96 0.07 0.60
Glutathione Transferase Omega-1 14 Target Disease Hyperglycemia 28,168 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.96 0.07 0.62
Glutathione Transferase Omega-1 14 Target Disease Inflammation 252,734 1 0.00 -0.96 0.07 0.56
Arava (Leflunomide)- FDA 14 Drug Disease Tuberculosis 146,217 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Inflammatory Bowel Disease 24,375 1 0.00 -0.96 0.07 0.61
Arava (Leflunomide)- FDA 14 Drug Disease Infection 766,637 1 0.00 -0.96 0.07 0.54
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis B 57,815 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Influenza 67,933 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Anemia 81,663 1 0.00 -0.96 0.07 0.58
Arava (Leflunomide)- FDA 14 Drug Disease Joint Pain 4,215 1 0.00 -0.96 0.07 0.65
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Ankylosing Spondylitis 9,665 1 0.00 -0.96 0.07 0.63
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58
Dronedarone Hydrochloride 14 Drug Disease Cancer 1,053,491 1 0.00 -0.96 0.07 0.53
Dronedarone Hydrochloride 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58